DBV Technologies (DBVT) Total Current Liabilities (2015 - 2026)

DBV Technologies (DBVT) posted Total Current Liabilities of $54.3 million for Q2 2026, up 4.83% sequentially from $51.8 million in Q1 2026, and up 9.86% YoY from $49.4 million in Q2 2025.

DBV Technologies (DBVT) Total Current Liabilities (2015 - 2026) Analysis & Trends

DBV Technologies has reported Total Current Liabilities for 12 years, with the latest figure at $54.3 million in Q2 2026.

  • Quarterly Total Current Liabilities rose 9.86% year-over-year to $54.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $54.3 million (up 9.86% YoY) and the FY2025 annual result came in at $58.0 million, up 86.28% from the prior year.
  • Total Current Liabilities improved to $54.3 million in Q2 2026 per DBVT's latest filing, from $51.8 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $58.0 million in Q4 2025 and troughed at $26.0 million in Q1 2022.
  • A 5-year average of $37.1 million and a median of $32.1 million in 2023 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Current Liabilities tumbled 32.96% in 2022, then surged 86.28% in 2025.
  • Over 5 years, Total Current Liabilities stood at $29.5 million in 2022, then climbed by 26.48% to $37.3 million in 2023, then dropped by 16.61% to $31.1 million in 2024, then surged by 86.28% to $58.0 million in 2025, then slipped by 6.38% to $54.3 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $54.3 million, $51.8 million, and $58.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.58 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 354.06 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 2.12 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 4.22 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 630.93 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.51 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 438.74 Mn
10 DBV Technologies 6.08 Bn 5.90 Bn - 54.30 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 54.30 Mn
Mar 31, 2026 51.80 Mn
Dec 31, 2025 58.00 Mn
Sep 30, 2025 49.49 Mn
Jun 30, 2025 49.43 Mn
Mar 31, 2025 40.38 Mn
Dec 31, 2024 31.14 Mn
Sep 30, 2024 30.91 Mn
Jun 30, 2024 27.38 Mn
Mar 31, 2024 26.48 Mn
Dec 31, 2023 37.34 Mn
Sep 30, 2023 31.44 Mn
Jun 30, 2023 33.37 Mn
Mar 31, 2023 32.78 Mn
Dec 31, 2022 29.52 Mn
Sep 30, 2022 28.39 Mn
Jun 30, 2022 30.43 Mn
Mar 31, 2022 26.03 Mn
Dec 31, 2021 31.40 Mn
Sep 30, 2021 33.81 Mn